Global Ocaliva Market Research Report 2023
Obeticholic acid is a semi-synthetic bile acid analogue which has the chemical structure 6?-ethyl-chenodeoxycholic acid.
According to QYResearch’s new survey, global Ocaliva market is projected to reach US$ 240.4 million in 2029, increasing from US$ 309 million in 2022, with the CAGR of -2.4% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Ocaliva market research.
The Ocaliva market is primarily driven by the urgent need for effective treatments for primary biliary cholangitis (PBC), a chronic liver disease that affects the bile ducts. Ocaliva, also known as obeticholic acid, is a medication used to manage PBC and improve liver function. The increasing prevalence of PBC, coupled with advancements in hepatology research and the focus on liver health, contributes to market growth. Moreover, the demonstrated benefits of Ocaliva in reducing serum alkaline phosphatase levels and delaying disease progression further propel adoption. However, challenges include managing potential side effects, optimizing dosing for individual patients, and addressing potential drug interactions. Navigating patient-specific treatment needs, ensuring long-term safety, and providing comprehensive monitoring are ongoing concerns. The market's success relies on continuous research in liver diseases, collaborations between pharmaceutical manufacturers and hepatologists, and comprehensive patient education on the benefits and potential risks of Ocaliva treatment while addressing the evolving challenges associated with liver disease management and treatment accessibility.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Ocaliva market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
According to QYResearch’s new survey, global Ocaliva market is projected to reach US$ 240.4 million in 2029, increasing from US$ 309 million in 2022, with the CAGR of -2.4% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Ocaliva market research.
The Ocaliva market is primarily driven by the urgent need for effective treatments for primary biliary cholangitis (PBC), a chronic liver disease that affects the bile ducts. Ocaliva, also known as obeticholic acid, is a medication used to manage PBC and improve liver function. The increasing prevalence of PBC, coupled with advancements in hepatology research and the focus on liver health, contributes to market growth. Moreover, the demonstrated benefits of Ocaliva in reducing serum alkaline phosphatase levels and delaying disease progression further propel adoption. However, challenges include managing potential side effects, optimizing dosing for individual patients, and addressing potential drug interactions. Navigating patient-specific treatment needs, ensuring long-term safety, and providing comprehensive monitoring are ongoing concerns. The market's success relies on continuous research in liver diseases, collaborations between pharmaceutical manufacturers and hepatologists, and comprehensive patient education on the benefits and potential risks of Ocaliva treatment while addressing the evolving challenges associated with liver disease management and treatment accessibility.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Ocaliva market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
- Intercept Pharmaceuticals
- Dainippon Sumitomo Pharma
- 5mg
- 10mg
- Primary Biliary Cirrhosis
- Nonalcoholic Fatty Liver Disease
- Other
- North America
- United States
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
1 OCALIVA MARKET OVERVIEW
1.1 Product Overview and Scope of Ocaliva
1.2 Ocaliva Segment by Type
1.2.1 Global Ocaliva Market Value Comparison by Type (2023-2029)
1.2.2 5mg
1.2.3 10mg
1.3 Ocaliva Segment by Application
1.3.1 Global Ocaliva Market Value by Application: (2023-2029)
1.3.2 Primary Biliary Cirrhosis
1.3.3 Nonalcoholic Fatty Liver Disease
1.3.4 Other
1.4 Global Ocaliva Market Size Estimates and Forecasts
1.4.1 Global Ocaliva Revenue 2018-2029
1.4.2 Global Ocaliva Sales 2018-2029
1.4.3 Global Ocaliva Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 OCALIVA MARKET COMPETITION BY MANUFACTURERS
2.1 Global Ocaliva Sales Market Share by Manufacturers (2018-2023)
2.2 Global Ocaliva Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Ocaliva Average Price by Manufacturers (2018-2023)
2.4 Global Ocaliva Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Ocaliva, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Ocaliva, Product Type & Application
2.7 Ocaliva Market Competitive Situation and Trends
2.7.1 Ocaliva Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Ocaliva Players Market Share by Revenue
2.7.3 Global Ocaliva Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 OCALIVA RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global Ocaliva Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Ocaliva Global Ocaliva Sales by Region: 2018-2029
3.2.1 Global Ocaliva Sales by Region: 2018-2023
3.2.2 Global Ocaliva Sales by Region: 2024-2029
3.3 Global Ocaliva Global Ocaliva Revenue by Region: 2018-2029
3.3.1 Global Ocaliva Revenue by Region: 2018-2023
3.3.2 Global Ocaliva Revenue by Region: 2024-2029
3.4 North America Ocaliva Market Facts & Figures by Country
3.4.1 North America Ocaliva Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Ocaliva Sales by Country (2018-2029)
3.4.3 North America Ocaliva Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Ocaliva Market Facts & Figures by Country
3.5.1 Europe Ocaliva Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Ocaliva Sales by Country (2018-2029)
3.5.3 Europe Ocaliva Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Ocaliva Market Facts & Figures by Country
3.6.1 Asia Pacific Ocaliva Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Ocaliva Sales by Country (2018-2029)
3.6.3 Asia Pacific Ocaliva Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Ocaliva Market Facts & Figures by Country
3.7.1 Latin America Ocaliva Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Ocaliva Sales by Country (2018-2029)
3.7.3 Latin America Ocaliva Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Ocaliva Market Facts & Figures by Country
3.8.1 Middle East and Africa Ocaliva Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Ocaliva Sales by Country (2018-2029)
3.8.3 Middle East and Africa Ocaliva Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 SEGMENT BY TYPE
4.1 Global Ocaliva Sales by Type (2018-2029)
4.1.1 Global Ocaliva Sales by Type (2018-2023)
4.1.2 Global Ocaliva Sales by Type (2024-2029)
4.1.3 Global Ocaliva Sales Market Share by Type (2018-2029)
4.2 Global Ocaliva Revenue by Type (2018-2029)
4.2.1 Global Ocaliva Revenue by Type (2018-2023)
4.2.2 Global Ocaliva Revenue by Type (2024-2029)
4.2.3 Global Ocaliva Revenue Market Share by Type (2018-2029)
4.3 Global Ocaliva Price by Type (2018-2029)
5 SEGMENT BY APPLICATION
5.1 Global Ocaliva Sales by Application (2018-2029)
5.1.1 Global Ocaliva Sales by Application (2018-2023)
5.1.2 Global Ocaliva Sales by Application (2024-2029)
5.1.3 Global Ocaliva Sales Market Share by Application (2018-2029)
5.2 Global Ocaliva Revenue by Application (2018-2029)
5.2.1 Global Ocaliva Revenue by Application (2018-2023)
5.2.2 Global Ocaliva Revenue by Application (2024-2029)
5.2.3 Global Ocaliva Revenue Market Share by Application (2018-2029)
5.3 Global Ocaliva Price by Application (2018-2029)
6 KEY COMPANIES PROFILED
6.1 Intercept Pharmaceuticals
6.1.1 Intercept Pharmaceuticals Corporation Information
6.1.2 Intercept Pharmaceuticals Description and Business Overview
6.1.3 Intercept Pharmaceuticals Ocaliva Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Intercept Pharmaceuticals Ocaliva Product Portfolio
6.1.5 Intercept Pharmaceuticals Recent Developments/Updates
6.2 Dainippon Sumitomo Pharma
6.2.1 Dainippon Sumitomo Pharma Corporation Information
6.2.2 Dainippon Sumitomo Pharma Description and Business Overview
6.2.3 Dainippon Sumitomo Pharma Ocaliva Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Dainippon Sumitomo Pharma Ocaliva Product Portfolio
6.2.5 Dainippon Sumitomo Pharma Recent Developments/Updates
7 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
7.1 Ocaliva Industry Chain Analysis
7.2 Ocaliva Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Ocaliva Production Mode & Process
7.4 Ocaliva Sales and Marketing
7.4.1 Ocaliva Sales Channels
7.4.2 Ocaliva Distributors
7.5 Ocaliva Customers
8 OCALIVA MARKET DYNAMICS
8.1 Ocaliva Industry Trends
8.2 Ocaliva Market Drivers
8.3 Ocaliva Market Challenges
8.4 Ocaliva Market Restraints
9 RESEARCH FINDING AND CONCLUSION
10 METHODOLOGY AND DATA SOURCE
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Overview and Scope of Ocaliva
1.2 Ocaliva Segment by Type
1.2.1 Global Ocaliva Market Value Comparison by Type (2023-2029)
1.2.2 5mg
1.2.3 10mg
1.3 Ocaliva Segment by Application
1.3.1 Global Ocaliva Market Value by Application: (2023-2029)
1.3.2 Primary Biliary Cirrhosis
1.3.3 Nonalcoholic Fatty Liver Disease
1.3.4 Other
1.4 Global Ocaliva Market Size Estimates and Forecasts
1.4.1 Global Ocaliva Revenue 2018-2029
1.4.2 Global Ocaliva Sales 2018-2029
1.4.3 Global Ocaliva Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 OCALIVA MARKET COMPETITION BY MANUFACTURERS
2.1 Global Ocaliva Sales Market Share by Manufacturers (2018-2023)
2.2 Global Ocaliva Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Ocaliva Average Price by Manufacturers (2018-2023)
2.4 Global Ocaliva Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Ocaliva, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Ocaliva, Product Type & Application
2.7 Ocaliva Market Competitive Situation and Trends
2.7.1 Ocaliva Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Ocaliva Players Market Share by Revenue
2.7.3 Global Ocaliva Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 OCALIVA RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global Ocaliva Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Ocaliva Global Ocaliva Sales by Region: 2018-2029
3.2.1 Global Ocaliva Sales by Region: 2018-2023
3.2.2 Global Ocaliva Sales by Region: 2024-2029
3.3 Global Ocaliva Global Ocaliva Revenue by Region: 2018-2029
3.3.1 Global Ocaliva Revenue by Region: 2018-2023
3.3.2 Global Ocaliva Revenue by Region: 2024-2029
3.4 North America Ocaliva Market Facts & Figures by Country
3.4.1 North America Ocaliva Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Ocaliva Sales by Country (2018-2029)
3.4.3 North America Ocaliva Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Ocaliva Market Facts & Figures by Country
3.5.1 Europe Ocaliva Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Ocaliva Sales by Country (2018-2029)
3.5.3 Europe Ocaliva Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Ocaliva Market Facts & Figures by Country
3.6.1 Asia Pacific Ocaliva Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Ocaliva Sales by Country (2018-2029)
3.6.3 Asia Pacific Ocaliva Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Ocaliva Market Facts & Figures by Country
3.7.1 Latin America Ocaliva Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Ocaliva Sales by Country (2018-2029)
3.7.3 Latin America Ocaliva Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Ocaliva Market Facts & Figures by Country
3.8.1 Middle East and Africa Ocaliva Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Ocaliva Sales by Country (2018-2029)
3.8.3 Middle East and Africa Ocaliva Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 SEGMENT BY TYPE
4.1 Global Ocaliva Sales by Type (2018-2029)
4.1.1 Global Ocaliva Sales by Type (2018-2023)
4.1.2 Global Ocaliva Sales by Type (2024-2029)
4.1.3 Global Ocaliva Sales Market Share by Type (2018-2029)
4.2 Global Ocaliva Revenue by Type (2018-2029)
4.2.1 Global Ocaliva Revenue by Type (2018-2023)
4.2.2 Global Ocaliva Revenue by Type (2024-2029)
4.2.3 Global Ocaliva Revenue Market Share by Type (2018-2029)
4.3 Global Ocaliva Price by Type (2018-2029)
5 SEGMENT BY APPLICATION
5.1 Global Ocaliva Sales by Application (2018-2029)
5.1.1 Global Ocaliva Sales by Application (2018-2023)
5.1.2 Global Ocaliva Sales by Application (2024-2029)
5.1.3 Global Ocaliva Sales Market Share by Application (2018-2029)
5.2 Global Ocaliva Revenue by Application (2018-2029)
5.2.1 Global Ocaliva Revenue by Application (2018-2023)
5.2.2 Global Ocaliva Revenue by Application (2024-2029)
5.2.3 Global Ocaliva Revenue Market Share by Application (2018-2029)
5.3 Global Ocaliva Price by Application (2018-2029)
6 KEY COMPANIES PROFILED
6.1 Intercept Pharmaceuticals
6.1.1 Intercept Pharmaceuticals Corporation Information
6.1.2 Intercept Pharmaceuticals Description and Business Overview
6.1.3 Intercept Pharmaceuticals Ocaliva Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Intercept Pharmaceuticals Ocaliva Product Portfolio
6.1.5 Intercept Pharmaceuticals Recent Developments/Updates
6.2 Dainippon Sumitomo Pharma
6.2.1 Dainippon Sumitomo Pharma Corporation Information
6.2.2 Dainippon Sumitomo Pharma Description and Business Overview
6.2.3 Dainippon Sumitomo Pharma Ocaliva Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Dainippon Sumitomo Pharma Ocaliva Product Portfolio
6.2.5 Dainippon Sumitomo Pharma Recent Developments/Updates
7 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
7.1 Ocaliva Industry Chain Analysis
7.2 Ocaliva Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Ocaliva Production Mode & Process
7.4 Ocaliva Sales and Marketing
7.4.1 Ocaliva Sales Channels
7.4.2 Ocaliva Distributors
7.5 Ocaliva Customers
8 OCALIVA MARKET DYNAMICS
8.1 Ocaliva Industry Trends
8.2 Ocaliva Market Drivers
8.3 Ocaliva Market Challenges
8.4 Ocaliva Market Restraints
9 RESEARCH FINDING AND CONCLUSION
10 METHODOLOGY AND DATA SOURCE
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
LIST OF TABLES
Table 1. Global Ocaliva Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Ocaliva Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Ocaliva Market Competitive Situation by Manufacturers in 2022
Table 4. Global Ocaliva Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Ocaliva Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Ocaliva Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Ocaliva Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Ocaliva Average Price (USD/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Ocaliva, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Ocaliva, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Ocaliva, Product Type & Application
Table 12. Global Key Manufacturers of Ocaliva, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Ocaliva by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ocaliva as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Ocaliva Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Ocaliva Sales by Region (2018-2023) & (K Units)
Table 18. Global Ocaliva Sales Market Share by Region (2018-2023)
Table 19. Global Ocaliva Sales by Region (2024-2029) & (K Units)
Table 20. Global Ocaliva Sales Market Share by Region (2024-2029)
Table 21. Global Ocaliva Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Ocaliva Revenue Market Share by Region (2018-2023)
Table 23. Global Ocaliva Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Ocaliva Revenue Market Share by Region (2024-2029)
Table 25. North America Ocaliva Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Ocaliva Sales by Country (2018-2023) & (K Units)
Table 27. North America Ocaliva Sales by Country (2024-2029) & (K Units)
Table 28. North America Ocaliva Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Ocaliva Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Ocaliva Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Ocaliva Sales by Country (2018-2023) & (K Units)
Table 32. Europe Ocaliva Sales by Country (2024-2029) & (K Units)
Table 33. Europe Ocaliva Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Ocaliva Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Ocaliva Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Ocaliva Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Ocaliva Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Ocaliva Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Ocaliva Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Ocaliva Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Ocaliva Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Ocaliva Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Ocaliva Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Ocaliva Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Ocaliva Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Ocaliva Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Ocaliva Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Ocaliva Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Ocaliva Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Ocaliva Sales (K Units) by Type (2018-2023)
Table 51. Global Ocaliva Sales (K Units) by Type (2024-2029)
Table 52. Global Ocaliva Sales Market Share by Type (2018-2023)
Table 53. Global Ocaliva Sales Market Share by Type (2024-2029)
Table 54. Global Ocaliva Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Ocaliva Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Ocaliva Revenue Market Share by Type (2018-2023)
Table 57. Global Ocaliva Revenue Market Share by Type (2024-2029)
Table 58. Global Ocaliva Price (USD/Unit) by Type (2018-2023)
Table 59. Global Ocaliva Price (USD/Unit) by Type (2024-2029)
Table 60. Global Ocaliva Sales (K Units) by Application (2018-2023)
Table 61. Global Ocaliva Sales (K Units) by Application (2024-2029)
Table 62. Global Ocaliva Sales Market Share by Application (2018-2023)
Table 63. Global Ocaliva Sales Market Share by Application (2024-2029)
Table 64. Global Ocaliva Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Ocaliva Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Ocaliva Revenue Market Share by Application (2018-2023)
Table 67. Global Ocaliva Revenue Market Share by Application (2024-2029)
Table 68. Global Ocaliva Price (USD/Unit) by Application (2018-2023)
Table 69. Global Ocaliva Price (USD/Unit) by Application (2024-2029)
Table 70. Intercept Pharmaceuticals Corporation Information
Table 71. Intercept Pharmaceuticals Description and Business Overview
Table 72. Intercept Pharmaceuticals Ocaliva Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 73. Intercept Pharmaceuticals Ocaliva Product
Table 74. Intercept Pharmaceuticals Recent Developments/Updates
Table 75. Dainippon Sumitomo Pharma Corporation Information
Table 76. Dainippon Sumitomo Pharma Description and Business Overview
Table 77. Dainippon Sumitomo Pharma Ocaliva Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 78. Dainippon Sumitomo Pharma Ocaliva Product
Table 79. Dainippon Sumitomo Pharma Recent Developments/Updates
Table 80. Key Raw Materials Lists
Table 81. Raw Materials Key Suppliers Lists
Table 82. Ocaliva Distributors List
Table 83. Ocaliva Customers List
Table 84. Ocaliva Market Trends
Table 85. Ocaliva Market Drivers
Table 86. Ocaliva Market Challenges
Table 87. Ocaliva Market Restraints
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
Table 1. Global Ocaliva Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Ocaliva Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Ocaliva Market Competitive Situation by Manufacturers in 2022
Table 4. Global Ocaliva Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Ocaliva Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Ocaliva Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Ocaliva Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Ocaliva Average Price (USD/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Ocaliva, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Ocaliva, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Ocaliva, Product Type & Application
Table 12. Global Key Manufacturers of Ocaliva, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Ocaliva by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ocaliva as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Ocaliva Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Ocaliva Sales by Region (2018-2023) & (K Units)
Table 18. Global Ocaliva Sales Market Share by Region (2018-2023)
Table 19. Global Ocaliva Sales by Region (2024-2029) & (K Units)
Table 20. Global Ocaliva Sales Market Share by Region (2024-2029)
Table 21. Global Ocaliva Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Ocaliva Revenue Market Share by Region (2018-2023)
Table 23. Global Ocaliva Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Ocaliva Revenue Market Share by Region (2024-2029)
Table 25. North America Ocaliva Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Ocaliva Sales by Country (2018-2023) & (K Units)
Table 27. North America Ocaliva Sales by Country (2024-2029) & (K Units)
Table 28. North America Ocaliva Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Ocaliva Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Ocaliva Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Ocaliva Sales by Country (2018-2023) & (K Units)
Table 32. Europe Ocaliva Sales by Country (2024-2029) & (K Units)
Table 33. Europe Ocaliva Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Ocaliva Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Ocaliva Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Ocaliva Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Ocaliva Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Ocaliva Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Ocaliva Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Ocaliva Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Ocaliva Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Ocaliva Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Ocaliva Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Ocaliva Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Ocaliva Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Ocaliva Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Ocaliva Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Ocaliva Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Ocaliva Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Ocaliva Sales (K Units) by Type (2018-2023)
Table 51. Global Ocaliva Sales (K Units) by Type (2024-2029)
Table 52. Global Ocaliva Sales Market Share by Type (2018-2023)
Table 53. Global Ocaliva Sales Market Share by Type (2024-2029)
Table 54. Global Ocaliva Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Ocaliva Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Ocaliva Revenue Market Share by Type (2018-2023)
Table 57. Global Ocaliva Revenue Market Share by Type (2024-2029)
Table 58. Global Ocaliva Price (USD/Unit) by Type (2018-2023)
Table 59. Global Ocaliva Price (USD/Unit) by Type (2024-2029)
Table 60. Global Ocaliva Sales (K Units) by Application (2018-2023)
Table 61. Global Ocaliva Sales (K Units) by Application (2024-2029)
Table 62. Global Ocaliva Sales Market Share by Application (2018-2023)
Table 63. Global Ocaliva Sales Market Share by Application (2024-2029)
Table 64. Global Ocaliva Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Ocaliva Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Ocaliva Revenue Market Share by Application (2018-2023)
Table 67. Global Ocaliva Revenue Market Share by Application (2024-2029)
Table 68. Global Ocaliva Price (USD/Unit) by Application (2018-2023)
Table 69. Global Ocaliva Price (USD/Unit) by Application (2024-2029)
Table 70. Intercept Pharmaceuticals Corporation Information
Table 71. Intercept Pharmaceuticals Description and Business Overview
Table 72. Intercept Pharmaceuticals Ocaliva Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 73. Intercept Pharmaceuticals Ocaliva Product
Table 74. Intercept Pharmaceuticals Recent Developments/Updates
Table 75. Dainippon Sumitomo Pharma Corporation Information
Table 76. Dainippon Sumitomo Pharma Description and Business Overview
Table 77. Dainippon Sumitomo Pharma Ocaliva Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 78. Dainippon Sumitomo Pharma Ocaliva Product
Table 79. Dainippon Sumitomo Pharma Recent Developments/Updates
Table 80. Key Raw Materials Lists
Table 81. Raw Materials Key Suppliers Lists
Table 82. Ocaliva Distributors List
Table 83. Ocaliva Customers List
Table 84. Ocaliva Market Trends
Table 85. Ocaliva Market Drivers
Table 86. Ocaliva Market Challenges
Table 87. Ocaliva Market Restraints
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Product Picture of Ocaliva
Figure 2. Global Ocaliva Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Ocaliva Market Share by Type in 2022 & 2029
Figure 4. 5mg Product Picture
Figure 5. 10mg Product Picture
Figure 6. Global Ocaliva Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Ocaliva Market Share by Application in 2022 & 2029
Figure 8. Primary Biliary Cirrhosis
Figure 9. Nonalcoholic Fatty Liver Disease
Figure 10. Other
Figure 11. Global Ocaliva Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Ocaliva Market Size (2018-2029) & (US$ Million)
Figure 13. Global Ocaliva Sales (2018-2029) & (K Units)
Figure 14. Global Ocaliva Average Price (USD/Unit) & (2018-2029)
Figure 15. Ocaliva Report Years Considered
Figure 16. Ocaliva Sales Share by Manufacturers in 2022
Figure 17. Global Ocaliva Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Ocaliva Players: Market Share by Revenue in 2022
Figure 19. Ocaliva Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Ocaliva Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America Ocaliva Sales Market Share by Country (2018-2029)
Figure 22. North America Ocaliva Revenue Market Share by Country (2018-2029)
Figure 23. United States Ocaliva Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada Ocaliva Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe Ocaliva Sales Market Share by Country (2018-2029)
Figure 26. Europe Ocaliva Revenue Market Share by Country (2018-2029)
Figure 27. Germany Ocaliva Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France Ocaliva Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. Ocaliva Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy Ocaliva Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia Ocaliva Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific Ocaliva Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific Ocaliva Revenue Market Share by Region (2018-2029)
Figure 34. China Ocaliva Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan Ocaliva Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea Ocaliva Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India Ocaliva Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia Ocaliva Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. China Taiwan Ocaliva Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Indonesia Ocaliva Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Thailand Ocaliva Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Malaysia Ocaliva Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Latin America Ocaliva Sales Market Share by Country (2018-2029)
Figure 44. Latin America Ocaliva Revenue Market Share by Country (2018-2029)
Figure 45. Mexico Ocaliva Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Brazil Ocaliva Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Argentina Ocaliva Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Ocaliva Sales Market Share by Country (2018-2029)
Figure 49. Middle East & Africa Ocaliva Revenue Market Share by Country (2018-2029)
Figure 50. Turkey Ocaliva Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia Ocaliva Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. UAE Ocaliva Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Global Sales Market Share of Ocaliva by Type (2018-2029)
Figure 54. Global Revenue Market Share of Ocaliva by Type (2018-2029)
Figure 55. Global Ocaliva Price (USD/Unit) by Type (2018-2029)
Figure 56. Global Sales Market Share of Ocaliva by Application (2018-2029)
Figure 57. Global Revenue Market Share of Ocaliva by Application (2018-2029)
Figure 58. Global Ocaliva Price (USD/Unit) by Application (2018-2029)
Figure 59. Ocaliva Value Chain
Figure 60. Ocaliva Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Figure 1. Product Picture of Ocaliva
Figure 2. Global Ocaliva Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Ocaliva Market Share by Type in 2022 & 2029
Figure 4. 5mg Product Picture
Figure 5. 10mg Product Picture
Figure 6. Global Ocaliva Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Ocaliva Market Share by Application in 2022 & 2029
Figure 8. Primary Biliary Cirrhosis
Figure 9. Nonalcoholic Fatty Liver Disease
Figure 10. Other
Figure 11. Global Ocaliva Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Ocaliva Market Size (2018-2029) & (US$ Million)
Figure 13. Global Ocaliva Sales (2018-2029) & (K Units)
Figure 14. Global Ocaliva Average Price (USD/Unit) & (2018-2029)
Figure 15. Ocaliva Report Years Considered
Figure 16. Ocaliva Sales Share by Manufacturers in 2022
Figure 17. Global Ocaliva Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Ocaliva Players: Market Share by Revenue in 2022
Figure 19. Ocaliva Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Ocaliva Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America Ocaliva Sales Market Share by Country (2018-2029)
Figure 22. North America Ocaliva Revenue Market Share by Country (2018-2029)
Figure 23. United States Ocaliva Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada Ocaliva Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe Ocaliva Sales Market Share by Country (2018-2029)
Figure 26. Europe Ocaliva Revenue Market Share by Country (2018-2029)
Figure 27. Germany Ocaliva Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France Ocaliva Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. Ocaliva Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy Ocaliva Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia Ocaliva Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific Ocaliva Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific Ocaliva Revenue Market Share by Region (2018-2029)
Figure 34. China Ocaliva Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan Ocaliva Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea Ocaliva Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India Ocaliva Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia Ocaliva Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. China Taiwan Ocaliva Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Indonesia Ocaliva Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Thailand Ocaliva Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Malaysia Ocaliva Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Latin America Ocaliva Sales Market Share by Country (2018-2029)
Figure 44. Latin America Ocaliva Revenue Market Share by Country (2018-2029)
Figure 45. Mexico Ocaliva Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Brazil Ocaliva Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Argentina Ocaliva Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Ocaliva Sales Market Share by Country (2018-2029)
Figure 49. Middle East & Africa Ocaliva Revenue Market Share by Country (2018-2029)
Figure 50. Turkey Ocaliva Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia Ocaliva Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. UAE Ocaliva Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Global Sales Market Share of Ocaliva by Type (2018-2029)
Figure 54. Global Revenue Market Share of Ocaliva by Type (2018-2029)
Figure 55. Global Ocaliva Price (USD/Unit) by Type (2018-2029)
Figure 56. Global Sales Market Share of Ocaliva by Application (2018-2029)
Figure 57. Global Revenue Market Share of Ocaliva by Application (2018-2029)
Figure 58. Global Ocaliva Price (USD/Unit) by Application (2018-2029)
Figure 59. Ocaliva Value Chain
Figure 60. Ocaliva Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
